Financials Sybleu Inc.

Equities

SYBE

US87114K1051

Pharmaceuticals

Delayed OTC Markets 20:59:37 22/05/2024 BST 5-day change 1st Jan Change
0.0185 USD -25.25% Intraday chart for Sybleu Inc. -25.40% -51.19%

Valuation

Fiscal Period: Juni 2023
Capitalization 1 3.02
Enterprise Value (EV) 1 3.494
P/E ratio -16.6 x
Yield -
Capitalization / Revenue 258,223,153 x
EV / Revenue 298,725,376 x
EV / EBITDA -
EV / FCF -165,063,164 x
FCF Yield -0%
Price to Book -8.77 x
Nbr of stocks (in thousands) 10,418
Reference price 2 0.2899
Announcement Date 04/08/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2020 2021 2022 2023
Net sales - 0.004052 0.0117 0.0117
EBITDA - - - -
EBIT 1 -0.039 -0.0821 -0.0545 -0.1464
Operating Margin - -2,027.07% -465.72% -1,251.48%
Earnings before Tax (EBT) 1 -0.0463 -0.0805 -0.2453 -0.1803
Net income 1 -0.0463 -0.1018 -0.2453 -0.1803
Net margin - -2,513.47% -2,096.98% -1,541.59%
EPS - -0.0101 -0.0236 -0.0175
Free Cash Flow - -0.026 -0.0395 -0.0212
FCF margin - -641.19% -337.97% -180.98%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 07/10/20 22/07/22 22/07/22 04/08/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: June 2020 2021 2022 2023
Net Debt 1 0.01 - 0.07 0.47
Net Cash position 1 - 0.01 - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - -0.03 -0.04 -0.02
ROE (net income / shareholders' equity) - 2,756% 193% 60%
ROA (Net income/ Total Assets) - -49.3% -24.7% -45%
Assets 1 - 0.2064 0.9939 0.4009
Book Value Per Share 2 -0 -0 -0.0200 -0.0300
Cash Flow per Share 2 0 0 0.0100 0
Capex - - - -
Capex / Sales - - - -
Announcement Date 07/10/20 22/07/22 22/07/22 04/08/23
1USD in Million2USD
Estimates
  1. Stock Market
  2. Equities
  3. SYBE Stock
  4. Financials Sybleu Inc.